Hint mode is switched on Switch off
For swift navigation between sections

Organization: Albany Molecular Research
LEI CHZJRCSC4ACUSUD2MV11

Organization name
Albany Molecular Research, Inc.
Country name
USA
Country of registration
USA
Industry
Professional Services
Bond debt
-

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. It operates through two segments, Large Scale Manufacturing; and Discovery, Drug Development, and Small-Scale Manufacturing.

Awards

News

30/04/2024 S&P Global Ratings affirms Albany Molecular Research at "CCC+" (Foreign Currency LT credit rating); outlook negative
30/04/2024 S&P Global Ratings affirms Albany Molecular Research at "CCC+" (Local Currency LT credit rating); outlook negative
22/04/2024 S&P Global Ratings affirms Albany Molecular Research at "CCC+" (Foreign Currency LT credit rating); outlook negative
22/04/2024 S&P Global Ratings affirms Albany Molecular Research at "CCC+" (Local Currency LT credit rating); outlook negative
29/09/2023 Moody's Investors Service downgrades LT- foreign currency credit rating of Albany Molecular Research to "Caa2"; outlook stable
All organization news

Documentation

IFRS/US GAAP reports

2017
I q eng
II q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Bond debt by currency

Show more Hide

Codes

  • LEI
    CHZJRCSC4ACUSUD2MV11
  • SIC
    8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
  • CIK
    0001065087

Credit and ESG Ratings

Macroeconomic Indicators - Albany Molecular Research

Registration is required to get access.